Open archive
Clear filters
Showing 1-7 of 7 published briefings.
Company archive
Ryman Healthcare (RYM) briefings
Read that company's published results in release order, newest first.
Ryman Healthcare (RYM)FY26Released 26 May 2026
Free cash flow swings to +NZ$188m as EBITDAF nearly doubles
Operating momentum is real but Ryman remains loss-making at the PBT line, and the FCF swing is partly capex-driven rather than purely earnings-led.
Published 26 May 2026
Read briefingRyman Healthcare (RYM)HY26Released 27 November 2025
PBT collapsed 123% to a NZ$40.2m loss as debt fell NZ$928m
Maiden NZ$56.2m FCF and the balance sheet reset frame the upside, but a NZ$152.7m receivables release flatters the cash result.
Published 21 April 2026
Read briefingRyman Healthcare (RYM)FY25Released 29 May 2025
EBITDAF tripled to $45.5m but NPAT loss widened to -$436.8m
Operating recovery is overshadowed by a capex surge to 70.4% of revenue and a -$94.2m free cash outflow.
Published 28 April 2026
Read briefingRyman Healthcare (RYM)HY25Released 28 November 2024
PBT up 21.9% but NPAT fell 49.4% on a tax-rate flip
A tax line that flipped from +30.2% to -46.0% drove the NPAT divergence while pre-lease free cash flow stayed below the historical range at -$52.5m.
Published 28 April 2026
Read briefingRyman Healthcare (RYM)HY24Released 29 November 2023
Dividend suspended as FCF stays $158.4m negative, PBT falls 34%
Headline NPAT declines just 3.8% on a 30.2% tax credit, but underlying profit is flat and pre-lease cash flow sits well below the historical range.
Published 28 April 2026
Read briefingRyman Healthcare (RYM)HY23Released 18 November 2022
NZ$281m working-capital build cut pre-lease FCF to NZ$51.8m as NPAT fell 31%
Underlying profit rose 44.8% but reported NPAT fell 31.1% as receivables expanded and capex jumped 56%, draining cash flow despite revenue growth.
Published 28 April 2026
Read briefingRyman Healthcare (RYM)FY22Released 17 June 2022
Reported NPAT jumped 63.8% but underlying profit grew only 13.6%
Investment property revaluations drove the headline gain while capex at 55.9% of revenue absorbed most of the operating cash flow expansion.
Published 29 April 2026
Read briefingGet reporting-season briefings
Get full NZX result briefings by email as new coverage is published.